Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
Learn facts and myths about the price of medicines, healthcare cost drivers and the economic contribution of industry.
StatsCan examines the economic footprint made by Canada’s research and development pharmaceutical sector in 2018, including the contributions of Innovative Medicines Canada.
The COVID-19 pandemic has graphically demonstrated the need for a better life sciences environment in Canada. This document outlines the industry’s recommendations for building a thriving sector.
Stay informed with timely, relevant content on key issues shaping our industry.